SCHEMBL6945832

SCHEMBL6945832

COC(C)COC(=O)C1=C(C)NC(C)=C(C(=O)OCC2CCCCC2)C1c1cccc(F)c1F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.54
TP53 P04637 3/20 0.49
CACNA1F O60840 6/20 0.46
CACNA1D Q01668 6/20 0.46
CACNA1S Q13698 6/20 0.46
CACNA1C Q13936 6/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ABCC4 O15439 1/20 0.44
NR1I2 O75469 1/20 0.44
ABCB11 O95342 1/20 0.44
LMNA P02545 1/20 0.44
NR3C1 P04150 1/20 0.44
CYP1A2 P05177 1/20 0.44
PGR P06401 1/20 0.44
ABCB1 P08183 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CNR1 P21554 1/20 0.44
ADORA2A P29274 1/20 0.44
ADORA1 P30542 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8091021 0.99 SMN1; SMN2 (0.52) SMN1; SMN2TP53CACNA1FCACNA1DCACNA1S
SCHEMBL6948567 0.87 SMN1; SMN2 (0.57) SMN1; SMN2TP53MEN1KMT2APDE1C
SCHEMBL6953510 0.86 SMN1; SMN2 (0.56) SMN1; SMN2TP53MEN1KMT2ACYP1A2
SCHEMBL8099097 0.78 SMN1; SMN2 (0.52) SMN1; SMN2TP53MEN1KMT2APDE1C
SCHEMBL8091377 0.77 SMN1; SMN2 (0.51) SMN1; SMN2TP53MEN1KMT2APDE1C
SCHEMBL6942333 0.76 CACNA1F (0.49) TP53CACNA1FCACNA1DCACNA1SCACNA1C
SCHEMBL6942341 0.76 CACNA1F (0.49) TP53CACNA1FCACNA1DCACNA1SCACNA1C
SCHEMBL3032439 0.75 MTOR (0.59) SMN1; SMN2TP53CACNA1CMEN1KMT2A
SCHEMBL13285115 0.74 CYP2C9 (0.67) TP53CACNA1FCACNA1DCACNA1SCACNA1C
SCHEMBL6942347 0.74 CACNA1F (0.47) TP53CACNA1FCACNA1DCACNA1SCACNA1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0657431-B1 4-Phenyl-3-substituted 1,4-dihydropyridine esters with cerebral activity BAYER AG (DE) 2003-02-19 EP claimed
US-6066655-A FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, IN PARTICULAR AS CEREBRAL THERAPEUTICS BAYER AKTIENGESELLSCHAFT (DE) 2000-05-23 US disclosed
US-5731333-A LEARNING AND MEMORY ENHANCEMENT, ANTIDEPRESSANTS BAYER AKTIENGESELLSCHAFT (DE) 1998-03-24 US disclosed